BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 18, 2016
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Apricus Biosciences completes direct public offering

Apricus Biosciences Inc. (NASDAQ:APRI), San Diego, Calif.
Business: Drug delivery, Genitourinary, Cancer
Date completed: 2016-01-13
Type: Direct public offering

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >